×
| Stock | Total Income | Net Profit | Net Sales | EPS | Market Cap (in Cr) | P/E |
|---|---|---|---|---|---|---|
| FABINO ENTERPRISES LIMITED | NA | NA | NA | NA | 5.46 | 91.0 |
| Triochem Products Ltd., | NA | NA | NA | NA | 0 | |
| KOVAI MEDICAL CENTER & HOSPITA | NA | NA | NA | NA | 6,900 | 119.0 |
| SUN PHARMA ADVANCED RESEARCH C | 187.8 | -518.7 | 96.4 | -1.6 | 5384 | |
| Supriya Lifescience Limited | 1477.48 | 347.9 | 1450.74 | 4.32 | 5249 | 29.5 |
Kovai Medical Center & Hospital Ltd, with Security Code 523323, is a leading player in the Hospital industry, categorized under the Healthcare sector, offering Equity instruments.
| Metrics | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 264.4 | 266.7 | 274.6 | 302.7 | 321.1 | 321.1 | 315.1 | 344.0 | 355.0 | 357.0 |
| Expenses | 193.0 | 199.9 | 206.2 | 217.5 | 224.8 | 229.4 | 228.8 | 248.5 | 252.1 | 255.8 |
| Operating Profit | 71.5 | 66.8 | 68.4 | 85.3 | 96.3 | 91.7 | 86.3 | 95.5 | 102.9 | 101.1 |
| OPM % | 27.02% | 25.04% | 24.92% | 28.17% | 30% | 28.55% | 27.37% | 27.76% | 28.98% | 28.33% |
| Other Income | 3.7 | 5.5 | 6.1 | 4.3 | 4.9 | 5.6 | 5.1 | 4.5 | 6.0 | 6.4 |
| Interest | 10.1 | 10.0 | 10.5 | 8.3 | 7.3 | 6.9 | 6.6 | 8.2 | 9.2 | 8.6 |
| Depreciation | 22.3 | 21.7 | 22.3 | 23.0 | 23.3 | 23.5 | 24.1 | 24.4 | 24.6 | 24.5 |
| Profit before tax | 42.7 | 40.7 | 41.8 | 58.4 | 70.5 | 66.9 | 60.7 | 67.4 | 75.1 | 74.4 |
| Tax % | -27.2% | -24.9% | -25.6% | -25.7% | -24.7% | -22% | -24.6% | -24.8% | -23.1% | -26.4% |
| Net Profit | 31.1 | 30.6 | 31.0 | 43.4 | 53.1 | 52.2 | 45.8 | 50.7 | 57.8 | 54.7 |
| EPS in Rs | 28.45 | 27.93 | 28.38 | 39.67 | 48.52 | 47.68 | 41.81 | 46.32 | 52.83 | 0 |
No Consolidated data available.
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 14% |
| 5 Years: | 14% |
| 3 Years: | 21% |
| TTM: | 15% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 25% |
| 3 Years: | 32% |
| TTM: | 31% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 59% |
| 3 Years: | 56% |
| 1 Year: | 36% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 21% |
| 5 Years: | 15% |
| 3 Years: | 14% |
| TTM: | 12% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 30% |
| 5 Years: | 23% |
| 3 Years: | 15% |
| TTM: | -3% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 25% |
| 5 Years: | 59% |
| 3 Years: | 56% |
| 1 Year: | 36% |
Recent Bets
|
Date
|
Stock
|
Party
|
Deal
|
Acq. Mode
|
Trans.
|
Quan.
|
Price
|
Value
|
|---|
| Period | SMA Value | Status |
|---|
| Period | EMA Value | Status |
|---|
| Indicator | Value |
|---|